PerkinElmer Partners with Cerep for Custom Drug Discovery Solutions

08-Apr-2008

PerkinElmer, Inc. and Cerep SA announced the signing of a supply and co-marketing agreement to deliver custom drug discovery services. Under the terms of the agreement, PerkinElmer will exclusively market Cerep's target screening and profiling services to its customers, and the companies will jointly promote PerkinElmer's assay technologies and Cerep services to the drug discovery market.

"This agreement represents the latest step in our strategy to build the most comprehensive offering in biochemical and cellular screening for drug discovery," said Robert F. Friel, president and chief executive officer, PerkinElmer, Inc. "Our customers will benefit from direct access to Cerep's expertise in high throughput screening and profiling services, while PerkinElmer will be able to extend the reach of our leading assay technologies and assay development services into key drug discovery markets."

This agreement provides PerkinElmer customers with an option to work with a single vendor throughout the entire drug discovery process. Cerep customers will now have access to several key assay development and detection platforms from PerkinElmer's Bio-discovery business.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!